ProHance (Bracco Diagnostics Inc)
Welcome to the PulseAid listing for the ProHance drug offered from Bracco Diagnostics Inc. This Magnetic Resonance Contrast Activity [MoA],Paramagnetic Contrast Agent [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Bracco Diagnostics Inc |
| NON-PROPRIETARY NAME: | gadoteridol |
| SUBSTANCE NAME: | GADOTERIDOL |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Magnetic Resonance Contrast Activity [MoA],Paramagnetic Contrast Agent [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2003-10-09 |
| END MARKETING DATE: | 0000-00-00 |
ProHance HUMAN PRESCRIPTION DRUG Details:
| Item Description | ProHance from Bracco Diagnostics Inc |
| LABELER NAME: | Bracco Diagnostics Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 279.3(mg/mL) |
| START MARKETING DATE: | 2003-10-09 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0270-1111_56b87355-3ad8-7109-744d-2e15a8e8e5a1 |
| PRODUCT NDC: | 0270-1111 |
| APPLICATION NUMBER: | NDA021489 |
Other GADOTERIDOL Pharmaceutical Manufacturers / Labelers:
